Palvella increases equity plan share reserve by 750,000 shares

Palvella Therapeutics amended its 2024 Equity Incentive Plan to increase available shares for issuance to 4,090,639 shares, approved by stockholders on June 10, 2026. The increase addresses anticipated future equity compensation needs for employee retention and incentives.